Durmaz Isa, Yagdi Tahir, Calkavur Tanzer, Mahmudov Resad, Apaydin Anil Z, Posacioglu Hakan, Atay Yüksel, Engin Cagatay
Department of Cardiovascular Surgery, Ege University Medical Faculty, Bornova, Izmir, Turkey.
Ann Thorac Surg. 2003 Mar;75(3):859-64. doi: 10.1016/s0003-4975(02)04635-0.
Preoperative creatinine values higher than 2.5 mg/dL are associated with markedly increased risk for both mortality and morbidity in patients undergoing coronary artery bypass surgery. We aimed to determine the effects of prophylactic perioperative hemodialysis on operative outcome in patients with nondialysis-dependent moderate renal dysfunction.
Forty-four adult patients with creatinine levels greater than 2.5 mg/dL but not requiring dialysis underwent coronary artery bypass surgery with cardiopulmonary bypass. The patients were randomly divided into two groups. In group 1 (dialysis group, 21 patients), perioperative prophylactic hemodialysis was performed in all patients. Group 2 (23 patients) was taken as a control group and hemodialysis was performed only if postoperative acute renal failure was diagnosed.
The hospital mortality was 4.8% (1 patient) in the dialysis group, and 30.4% (7 patients) in the control group (p = 0.048). Postoperative acute renal failure requiring hemodialysis was seen in 1 patient (4.8%) in the dialysis group and in 8 patients (34.8%) in the control group (p = 0.023). Thirty-three postoperative complications were observed in the control group for an early morbidity of 52.2% (12 patients) and 13 complications occurred in 8 patients in the dialysis group (38.1%). The average length of the intensive care unit and postoperative hospital stay were shorter in the dialysis group than in the control group (p = 0.005 and p = 0.023, respectively).
Preoperative creatinine levels higher than 2.5 mg/dL, increase the risk of mortality and the development of acute renal failure and prolong the length of hospital stay after on-pump coronary artery bypass surgery. Perioperative prophylactic hemodialysis decreases both operative mortality and morbidity in these high-risk patients.
术前肌酐值高于2.5mg/dL与接受冠状动脉搭桥手术患者的死亡率和发病率显著增加相关。我们旨在确定围手术期预防性血液透析对非透析依赖型中度肾功能不全患者手术结局的影响。
44例肌酐水平大于2.5mg/dL但不需要透析的成年患者接受了体外循环下的冠状动脉搭桥手术。患者被随机分为两组。第1组(透析组,21例患者)所有患者均进行围手术期预防性血液透析。第2组(23例患者)作为对照组,仅在诊断为术后急性肾衰竭时进行血液透析。
透析组医院死亡率为4.8%(1例患者),对照组为30.4%(7例患者)(p = 0.048)。透析组1例患者(4.8%)出现需要血液透析的术后急性肾衰竭,对照组8例患者(34.8%)出现(p = 0.023)。对照组观察到33例术后并发症,早期发病率为52.2%(12例患者),透析组8例患者出现13例并发症(38.1%)。透析组重症监护病房平均住院时间和术后住院时间均短于对照组(分别为p = 0.005和p = 0.023)。
术前肌酐水平高于2.5mg/dL会增加死亡率、急性肾衰竭的发生风险,并延长体外循环冠状动脉搭桥手术后的住院时间。围手术期预防性血液透析可降低这些高危患者的手术死亡率和发病率。